Multicomponent Exercise in People With Dementia

August 21, 2021 updated by: Yea-Ru Yang, National Yang Ming University

Effect of Multicomponent Exercise on Cognitive Function and Activities of Daily Living in People With Dementia

People with dementia shows a decline in cognition, such as memory, executive function (EF), language, attention, and spatial orientation that is significant enough to interfere with the independence and daily functioning. Previous studies reported that multicomponent exercise improved EF in people with mild cognitive impairment and independence of ADL in those with Alzheimer's disease. However, few studies investigated whether multicomponent exercise improved EF, memory, and ADL in people with dementia. Therefore, the purposes of this study are to examine 1) the effect of multicomponent exercise on EF, memory, and ADL in people with mild to moderate dementia; 2) the correlation between change in EF and ADL; 3) the correlation between change in memory and ADL.

Study Overview

Status

Not yet recruiting

Conditions

Study Type

Interventional

Enrollment (Anticipated)

52

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age: 60-80 y/o
  • Mini-Mental State Examination: 10-26
  • Clinical Dementia Rating: 1-2
  • Walk at least 6 meters independently (with or without walking aids)

Exclusion Criteria:

  • Any other diagnosis of neurological diseases or musculoskeletal problems (Except dementia)
  • Physical or psychological comorbidities that affect performance during assessment or intervention
  • Already participating in other physical training in the last 1 month

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Multicomponent exercise group
The intervention is a 60-minute session, 3 times/week, totaling 9 weeks. Multicomponent exercise included strengthening, balance training, aerobic dance, and stretching
Active Comparator: Video home exercise group
The intervention is a 60-minute session, 3 times/week, totaling 9 weeks. Video home exercise included four limbs mobility exercise, stretching, strengthening, and aerobic exercise

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mini-Mental State Examination
Time Frame: Change from baseline at 9 week
It is a 30-point questionnaire that is used extensively in clinical and research settings to measure cognitive impairment. Higher scores mean a better outcome.
Change from baseline at 9 week
Chinese version of Verbal learning test
Time Frame: Change from baseline at 9 week
It is a 9-point measurement to evaluate memory. Higher scores mean a better outcome.
Change from baseline at 9 week
Chinese version of Stroop color and word test
Time Frame: Change from baseline at 9 week
It is a measurement to evaluate inhibition control.
Change from baseline at 9 week
Digit span test
Time Frame: Change from baseline at 9 week
It is a measurement to evaluate working memory.
Change from baseline at 9 week
Trail making test - Chinese version
Time Frame: Change from baseline at 9 week
It is a measurement to evaluate cognitive flexibility.
Change from baseline at 9 week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Barthel index
Time Frame: Change from baseline at 9 week
It is a 100-point ordinal scale used to measure performance in activities of daily living. Higher scores mean a better outcome.
Change from baseline at 9 week
Instrumental activities of daily living (IADL) scale
Time Frame: Change from baseline at 9 week
It is a 24-point ordinal scale used to measure performance in instrumental activities of daily living. Higher scores mean a better outcome.
Change from baseline at 9 week
Chinese version of Quality of Life in Alzheimer Disease Scale
Time Frame: Change from baseline at 9 week
It is a measurement to evaluate quality of life. The scale scores range from 13 to 52, with higher scores indicating greater quality of life.
Change from baseline at 9 week
Time up and go test
Time Frame: Change from baseline at 9 week
It is a test to evaluate functional mobility.
Change from baseline at 9 week
30-second chair stand test
Time Frame: Change from baseline at 9 week
It is a test to evaluate muscle strength.
Change from baseline at 9 week
6-minute walk test
Time Frame: Change from baseline at 9 week
It is a test to evaluate endurance.
Change from baseline at 9 week
Berg Balance Scale
Time Frame: Change from baseline at 9 week
It is a tool to evaluate balance. It is a 14 item list with each item consisting of a five-point ordinal scale ranging from 0 to 4, with 0 indicating the lowest level of function and 4 the highest level of function.
Change from baseline at 9 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

September 1, 2021

Primary Completion (Anticipated)

December 31, 2022

Study Completion (Anticipated)

December 31, 2022

Study Registration Dates

First Submitted

June 18, 2021

First Submitted That Met QC Criteria

June 25, 2021

First Posted (Actual)

July 6, 2021

Study Record Updates

Last Update Posted (Actual)

August 24, 2021

Last Update Submitted That Met QC Criteria

August 21, 2021

Last Verified

August 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dementia

Clinical Trials on Multicomponent exercise

3
Subscribe